Clinical Evidence

QV Dermcare Eczema Daily Clinical Results

July 04, 2023
clear glass molecular model

The information is for educational purposes only and is not intended as a substitute for medical advice. Eczema requires diagnosis by a medical practitioner. See your medical practitioner for further information. 

A 28-day clinical trial on usage of QV Dermcare Eczema Daily Wash and Daily Cream was carried out on 100 adults with Eczema. QV Dermcare range,  when used together,  achieved significant reduction in Trans-Epidermal Moisture Loss (TEWL)  as compared to the placebo cream and wash1

graph showing dermcare eczema daily cream and wash improving skin hydration

Figure 1 - With QV Dermcare Eczema Daily Cream and Wash, skin hydration improved significantly compared to the placebo group over the 28 days1.*P <0.05 vs placebo.

graph showing dermcare eczema daily cream and wash significantly reducing transepidermal water loss

Figure 2 - Trans-Epidermal Water Loss (TEWL) in the QV Dermcare Eczema Daily Cream & Wash group vs placebo group. 

Over the 28-day study period (*P<0.05 vs placebo), the group also reported that they experienced skin softness, smoothness and indicated better itch relief than the placebo1

Always read the label and follow the directions for use. 

By Josh Townley, PhD .

Josh is a science writer with 10 years of experience in the pharmaceutical and skincare world, first developing products in the R&D lab, then registering them in the regulatory department. He has a PhD in chemistry and a bachelor’s degree in forensic science.

You Might Be Interested In

QV Singapore Subscription Form